 |
 |
Sales & Marketing
|
 |
 |
 |
|
 |
|
 |
|
 |
|
 |
|
| Title |
|
Pharmaceutical Distribution in the US |
|
| Sub title |
|
|
|
| Author |
|
R Findlay |
|
| Publication date |
|
November 1998 |
|
| ISBN |
|
|
|
| Pages |
|
Information currently unavailable |
|
| Price |
|
pdf n/a | print £150 |
 |
 |
Summary
The pharmaceutical wholesale trade in the USA has seen further consolidation in recent years, with the top four companies representing over 50% of the market. Pressure to contain costs and the prevalence of thin operating margins, has affected business confidence in certain areas. This report identifies the dramatic changes in distribution in the near future. Explaining how further impacts on wholesalers' margins are coming from the supply side, this report shows how the retail trade is in even greater state of change than the wholesaler side.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 TABLE OF CONTENTS |
 |
Contents
Executive Summary
Chapter 1: Overview of the healthcare market
Chapter 2: The distribution chain
Chapter 3: Channel analysis
Chapter 4: Product profiles
Chapter 5: Regional profiles
Chapter 6: The economics of distribution
Chapter 7: Short profiles of leading wholesalers
Chapter 8: Evolutionary changes among wholesalers
Chapter 9: Globalisation of wholesalers
Chapter 10: Alternative channels of distribution
Chapter 11: Future scenarios
|
|
|
|
Sales & Marketing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
| No additional author information available for this product |
|
|
|
|
|
